All the news Showing 10 of 63 articles from: FranceGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment for people who use drugs Conditional cash transfers may improve HCV screening and treatment in drug users Keith Alcorn / 22 January 2019 Conditional cash transfers – giving money to encourage use of services – may be needed to reach drug users for hepatitis C testing and treatment if they are either unaware of hepatitis ... Treatment for people living with HIV and HCV Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer Keith Alcorn / 04 January 2019 People with HIV and hepatitis C are no longer at higher risk of end-stage liver disease than people with hepatitis C alone, and the trend is probably associated with the improved effectiveness ... Treatment for people who use drugs France: people who inject drugs often given cheaper, less effective, hepatitis C medication Manual Items / 17 July 2018 Diagnosis and monitoring Cost-effective universal screening for hepatitis C in France EurekAlert (press release) / 02 July 2018 Treatment in cirrhosis Sustained virological response reduces risk of serious cardiovascular disease in people with HCV-related compensated cirrhosis Michael Carter / 27 April 2018 Successful hepatitis C virus (HCV) therapy reduces the risk of a serious cardiovascular event in people with compensated liver cirrhosis, French investigators report in the American Heart Journal. A sustained ... Hepatocellular carcinoma (HCC) Liver Cancer Caused by Alcohol Consumption May Have Worse Prognosis than Other Forms Wiley press release / 03 April 2018 Sexual transmission Spread of Hep C Is on the Rise Among French Gay & Bi Men With HIV Manual Items / 26 March 2018 Fibrosis People with HIV are at risk for liver fibrosis and steatosis Michael Carter / 21 August 2017 Metabolic syndrome, type 2 diabetes and obesity are risk factors for the development of liver fibrosis and steatosis (liver fat accumulation) in people living with HIV, including those who do ... Treatment in cirrhosis Antibiotic prophylaxis reduces the risk of short-term death in people with decompensated cirrhosis Keith Alcorn / 20 April 2017 Long-term prophylaxis with the antibiotic norfloxacin significantly reduced the incidence of deaths in people with decompensated cirrhosis over a six-month follow-up period, a French randomised trial reported today at the International Liver Congress ... Finance, funding & health economics France Reaches Agreement With Gilead To Drop Prices Of Hepatitis C Treatment Intellectual Property Watch / 03 April 2017 ← Prev12345...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive